Stimulation of Cellular Proliferation by Hepatitis B Virus X Protein
Authors:
Open Access
- 1 January 2001
- journal article
- review article
- Published by Wiley in Disease Markers
- Vol. 17 (3) , 153-157
Abstract
Chronic infection with the hepatitis B virus (HBV) is a known risk factor in the development of human hepatocellular carcinoma (HCC). The HBV‐encoded X protein, HBx, has been investigated for properties that may explain its cancer cofactor role in transgenic mouse lines. We discuss here recent data showing that HBx is able to induce hepatocellular proliferation in vitro and in vivo. This property of HBx is predicted to sensitize hepatocytes to other HCC cofactors, including exposure to carcinogens and to other hepatitis viruses. Cellular proliferation is intimately linked to the mechanism(s) by which most tumor‐associated viruses transform virus‐infected cells. The HBx alteration of the cell cycle provides an additional mechanism by which chronic HBV infection may contribute to HCC.Keywords
Funding Information
- National Institutes of Health (CA54557, T32DK07664)
- National Institute of Diabetes and Digestive and Kidney Diseases (CA54557, T32DK07664)
This publication has 36 references indexed in Scilit:
- Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesisMutation Research/DNA Repair, 2000
- Overexpression of p53 protein is not directly related to hepatitis B x protein expression and is associated with neoplastic progression in hepatocellular carcinomas rather than hepatic preneoplasiaMutation Research - Reviews in Mutation Research, 2000
- Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1Hepatology, 1999
- Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesisCancer Letters, 1998
- p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitroOncogene, 1998
- The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic miceOncogene, 1997
- Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virusX geneMolecular Carcinogenesis, 1996
- Functional inactivation but not structural mutation of p53 causes liver cancerNature Genetics, 1995
- HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 1991
- The p53 protein and its interactions with the oncogene products of the small DNA tumor virusesVirology, 1990